Ambrisentan Tablets and Insulin lispro Subcutaneous
Determining the interaction of Ambrisentan Tablets and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Insulin NPH
- Ambrisentan Tablets-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Ambrisentan Tablets-Insulin NPH (Vials)
- Ambrisentan Tablets-Insulin NPH and Insulin Regular
- Ambrisentan Tablets-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Ambrisentan Tablets-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Amcinonide
- Insulin lispro Subcutaneous-Amcinonide Cream and Ointment
- Insulin lispro Subcutaneous-Amcinonide Lotion
- Insulin lispro Subcutaneous-Amcinonide Ointment
- Insulin lispro Subcutaneous-Amcinonide topical
- Insulin lispro Subcutaneous-Amcinonide Topical application